Quantum Biopharma (QNTM) Generating A Significant Buzz with Shares Up 230% YTD
Biopharmaceutical company Quantum BioPharma (QNTM) has seen its stock rocket up roughly 230% in the past month. The company ...
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...
Nasdaq3d
Quantum BioPharma Ltd. Engages PR and Investor Awareness Firms to Enhance Market Presence
Corporate Product Updates unbuzzd™ is a rapid alcohol detoxification ... to maintain a portfolio of strategic investments through FSD Strategic Investments Inc.; Enterprise and Empire playing ...
Nasdaq9d
Quantum BioPharma Ltd. Announces Positive Results from Clinical Trial of unbuzzd™ Dietary Supplement for Alcohol Intoxication Relief
unbuzzd™ was well-tolerated and safe ... a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential ...
Benzinga.com7d
2QNTM : Quantum BioPharma Shares Are Up Over 80%: What's Going On?
Quantum BioPharma holds a 25.71% stake in Celly Nutrition and earns royalties from unbuzzd sales. NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts Quantum BioPharma Ltd. QNTM shares are ...
Yahoo Finance9d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company ...
Morningstar10d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
Results of data analysis show definitively that unbuzzd™ accelerated the rate at which Blood Alcohol Concentration (“BAC”) was reduced in study subjects, while simultaneously reducing the ...